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cohorts. Furthermore, nicotine dependence was signifi -
cantly associated with illicit substance use disorders 
(HR = 2.6, 95% CI 1.7–4.0). An interactive relationship be-
tween age, age at onset of nicotine dependence, and 
subsequent onset of illicit substance use disorders was 
found.  Conclusions: Since the baseline investigation in 
1995, high incidence rates of substance use disorders 
and substance use have been observed in this young 
German sample. Especially younger cohorts report sig-
nifi cantly earlier ages at onset of abuse and dependence. 
There also seems to be a trend towards a secondary age 
at onset peak of nicotine dependence after the onset of 
illicit drug use disorders. Further investigations are need-
ed to study these patterns in younger samples. However, 
results emphasize the need for a combined prevention 
of illicit drugs and nicotine dependence. 
 Copyright © 2006 S. Karger AG, Basel 
 Introduction 
 Prevalence of Substance Use Disorders:
Findings in the General Population 
 In the last three decades many epidemiological studies 
of substance use and substance use disorders have been 
conducted with adult and adolescent samples in the Unit-
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 Abstract 
 Objective: We present the prevalence and incidence 
rates of alcohol, nicotine, and illicit substance use, abuse, 
and dependence in a sample of German adolescents and 
young adults. Patterns of onset, cohort trends, and use 
of various substance classes are also analyzed.  Method: 
A prospective longitudinal epidemiological study with a 
representative sample of adolescents and young adults 
(n = 3,021; baseline age range = 14–24 years) was con-
ducted in Munich, Germany. Participants were assessed 
between 1995 and 1999 with the Munich-Composite In-
ternational Diagnostic Interview.  Results: Cumulative 
lifetime incidence (up to age 28) of any substance abuse 
or dependence was 43.8%, and 12-month prevalence of 
any substance abuse or dependence was 24.4%. The life-
time incidence of nicotine dependence was most fre-
quent (24.8%), followed by alcohol abuse (19.3%) and 
alcohol dependence (9.2%); 61.7% endorsed the regular 
use of a substance for at least one circumscribed period 
during their lifetime. Age-specifi c incidence rates and 
age at onset of substance use disorders differed by age 
 
European
Addiction
cRe es ar h
 Axel Perkonigg 
 Department of Clinical Psychology and Epidemiology, Max Planck Institute of Psychiatry 
 Kraepelinstrasse 2–10 
 DE–80804 Munich (Germany) 
 Tel. +49 89 30622 244, Fax +49 89 30622 544, E-Mail axel@mpipsykl.mpg.de 
 © 2006 S. Karger AG, Basel 
 1022–6877/06/0124–0187$23.50/0 
 Accessible online at: 
 www.karger.com/ear 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
4/
20
17
 1
0:
04
:5
4 
AM
 Perkonigg  /Pﬁ ster  /Höﬂ er  /Fröhlich  /
Zimmermann  /Lieb  /Wittchen  
 
 Eur Addict Res 2006;12:187–196 188
ed States and the European Union. Prevalence estimates 
vary depending on age, gender, or other sample charac-
teristics, as well as by assessment strategies and deﬁ ni-
tions for substance use disorders. Using DSM-III-R cri-
teria, Kessler et al.  [1] reported lifetime prevalence esti-
mates of 9.4% for alcohol abuse and 14.1% for alcohol 
dependence as well as 4.4% for drug abuse and 7.5% for 
drug dependence from the US National Comorbidity Sur-
vey in 1994. The 12-month estimates were lower with 
7.2% for alcohol dependence and 2.5% for alcohol abuse 
whereas only 2.8% fulﬁ lled criteria for drug dependence 
and 0.8% for drug abuse. A decade later the National Co-
morbidity Survey Replication found a different distribu-
tion of the abuse and dependence estimates based on 
DSM-IV criteria. 13.2% of the population fulﬁ lled crite-
ria for a lifetime diagnosis of alcohol abuse and a much 
lower proportion of 5.4% for alcohol dependence. The 
lifetime prevalence of drug abuse was 7.9% compared to 
3.0% with drug dependence  [2] . These higher rates of 
DSM-IV abuse were conﬁ rmed for the 12-month esti-
mates with 3.1% diagnosed as having alcohol abuse and 
only 1.3% fulﬁ lling criteria for dependence. Drug abuse 
was estimated with a 12-month prevalence of 1.4% and 
drug dependence with 0.4%  [3] . 12-month estimates of 
nicotine dependence in the USA have been reported from 
the National Epidemiologic Survey on Alcohol and Re-
lated Conditions  [4] . 12.8% of the population met criteria 
for a DSM-IV nicotine dependence. 
 European data about substance use disorders vary be-
tween countries. 12-month alcohol dependence estimates 
including all studies in the European Union and Norway 
with proven instruments and established criteria range 
from 0.4 to 14.5% in males and from 0.1 to 4.2% in fe-
males  [5] . 12-month drug dependence was estimated be-
tween 0.3 and 2.9%. These rates however seem to be low-
er bound estimates when taking hidden populations into 
account  [6] . 
 Prevalence of Substance Use Disorders:
Findings among Adolescents 
 A series of prospective and longitudinal studies with 
adolescent samples have shown that adolescence is the 
period that carries the highest risk of substance use onset. 
But comparisons are also difﬁ cult despite the use of stan-
dard criteria for abuse and dependence  [7] . Some bench-
mark data for the USA for the ages 15–18 years can be 
drawn from the US National Comorbidity Survey. War-
ner et al.  [8] found a lifetime prevalence of 9.7% for DSM-
III-R alcohol abuse and dependence in this age group, 
whereas 6.2% met criteria for illicit substance abuse or 
dependence. A more recent study using DSM-IV criteria 
for abuse and dependence reported lifetime prevalence 
estimates of 26% for substance abuse and 21.5% for sub-
stance dependence in a community sample of 18-year-
olds in Colorado  [9] . However, recent reports from the 
US Center for Disease Control and Prevention show that 
among adolescents nicotine and especially cannabis use 
seem to have declined slightly whereas rates for other 
drugs (e.g., cocaine) have been stable  [10] . Yet the overall 
rate of illicit drug use in the USA is still very high, with 
about 50% of all adolescents having tried at least one il-
licit drug before ﬁ nishing high school  [11] . 
 This slightly downward trend in the use of certain sub-
stances has not yet been observed in the European Union 
although rates from individual countries vary markedly. 
England (19.2%) and Spain (17.3%) appear to have the 
highest 12-month prevalence estimates for cannabis use 
among adolescents and young adults  [12] . Other illicit 
substances do not rate higher than 5% in these countries. 
In Germany, a recent school survey revealed a lifetime 
prevalence of frequent nicotine use ( 1 40 times) of 42.3% 
among 9th and 10th graders, 15 or 16 years old. More 
than 40% of these students reported frequent lifetime al-
cohol use ( 1 40 times) and about 17% had used any illicit 
drug  [13] . Although trends among adolescents have been 
closely monitored in many European Union countries, 
most study participants have been assessed with ques-
tionnaires in repeated cross-sectional studies. Epidemio-
logical studies that employ standardized clinical inter-
views based on DSM-IV or ICD-10 criteria are still rare 
in studies of substance use among adolescent popula-
tions. 
 Objectives of This Study 
 We attempted to address this shortcoming of existing 
studies by conducting a 42-month prospective, longitudi-
nal study of a randomly sampled German community 
cohort of adolescents and young adults. In this article, we 
follow up on prior studies that presented the baseline and 
initial follow-up data on the prevalence of use of speciﬁ c 
substance classes and substance use disorders in German 
adolescents and young adults  [14–16 ; www.asat-verbund.
de]. We expand on previously published follow-up data 
on speciﬁ c substances  [17, 18] by reporting 42-month in-
cidence, cumulative lifetime incidence, and 12-month 
prevalence of regular nicotine and alcohol use as well as 
repeated and regular illicit drug use and abuse, and de-
pendence. Additionally, we explore patterns of onset, co-
hort trends for all classes of substances, and patterns of 
pure and multiple lifetime use. 
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 Methods 
 Sample and Overall Design 
 Data were collected as part of the Early Developmental Stages 
of Psychopathology (EDSP) study. The sample and design of this 
study have been described elsewhere  [19, 20] . Brieﬂ y, the EDSP 
was designed to explore the prevalence and incidence, familial and 
other risk factors, comorbidity, and course of substance use and 
substance use disorders in a representative population sample of 
adolescents and young adults. The study is divided into three 
waves: the ﬁ rst was conducted in 1995 (baseline, with all 14- to 24-
year-olds; n = 3,021); the second in 1996/1997 (with only subjects 
who were 14–17 years old at baseline; n = 1,228), and the third in 
1998/1999 (again with all 14- to 24-year-olds at baseline; n = 
2,548). 
 The representative community sample was randomly drawn 
from government registries in Munich, Germany. Because the 
study was designed as a longitudinal panel with special emphasis 
on early developmental stages, 14- and 15-year-olds were sampled 
at twice the probability of people aged 16–21 years, and 22- to 24-
year-olds were sampled at half this probability. All participants 
provided informed consent. At baseline, a total of 3,021 interviews 
were completed, resulting in a response rate of 71%. The ﬁ rst fol-
low-up was conducted on average 19.7 (range 15–25.6) months 
after baseline with a response rate of 88%. Only the younger cohort 
(14- to 17-year-olds at baseline) was included in this wave. The 
second follow-up was conducted in 1998/99, an average of 42 
(range 34–50) months after baseline with a response rate of 84% of 
all baseline participants (n = 2,548). The study design was approved 
by the Ethics Committee of the Max Planck Society. 
 Sociodemographic characteristics of the baseline and follow-up 
samples have been published  [20] . Brieﬂ y, at baseline, most of the 
respondents were attending school (89%) and living with their par-
ents (98%); about 10% were in job training. The majority was clas-
siﬁ ed as belonging to the middle class (61%). Noteworthy changes 
from baseline to the second follow-up were found for school (fol-
low-up 42% attended school) and employment status (follow-up 
24% were in job training programs and 12% were employed). 
 Instrument 
 In all three waves, the computer-assisted version of the Munich-
Composite International Diagnostic Interview (M-CIDI) was used 
 [21] . The M-CIDI allows the standardized assessment of a wide 
range of DSM-IV substance use and mental disorders along with 
information about onset, duration, and clinical and psychosocial 
severity. In all assessments the M-CIDI was supplemented by a 
separate respondents’ booklet that included several scales and ques-
tionnaires for assessing psychological constructs relevant to the 
study. Detailed information on the validity and reliability of the 
M-CIDI has been presented elsewhere  [22, 23] . Inter-rater reliabil-
ity of the M-CIDI was fair to good, with Kappa values ranging from 
0.64 (Yules Y = 0.80) to 0.78 (Yules Y = 0.82). Lifetime and 12-
month diagnoses were generated at the baseline investigation. For 
the two follow-up investigations, the M-CIDI was modiﬁ ed to cov-
er the 12-month period prior to the follow-up interview, as well as 
the remaining interval between the investigations. Additional ques-
tions about the course since the preceding investigation were in-
cluded in a 12-month-interval version of the M-CIDI. 
 Assessment of Substance Use and Substance Use Disorders 
 Sections B (nicotine), I (alcohol), and L (drugs) of the M-CIDI 
refer to substance use (frequency and quantity), as well as abuse 
and dependence as deﬁ ned by DSM-IV  [24] . These sections start 
with a screen for use of the substances, followed by questions on 
the frequency and quantity of use, and then symptoms of abuse and 
dependence. All sections close with questions regarding the onset, 
duration, and recency of use and symptoms. The respondents’ 
booklet contained illustrative ﬁ gures for different kinds of drinks 
that were used to help the respondent accurately report the quan-
tity of alcohol use. In the drug section, the use of psychotropic pre-
scription substances is assessed ﬁ rst. Further assessment is con-
ducted if it appears that the participant has misused prescription 
drugs. For assessment of illicit substances, a list containing speciﬁ c 
substances together with their ‘street names’ is presented that al-
lows probing for 8 classes: cannabis, amphetamines, opioids, co-
caine, phencyclidine, hallucinogens, inhalants, and sedatives/hyp-
notics/anxiolytics. An open category of any other substances and a 
category of polysubstance use are also included. Symptoms of 
DSM-IV abuse and dependence of illicit substances were only as-
sessed if a substance had been used more than 4 times. The illicit 
drug use section was not administered to individuals who refused 
to respond openly. Inter-rater reliability of these CIDI sections is 
in the acceptable range (kappas = 0.55–0.64). Good agreement was 
found between clinician-assigned DSM-IV substance use diagnoses 
and those assigned according to the M-CIDI DSM-IV algorithms 
(Kappa = 0.86). 
 For each type of substance, we refer to the following categories 
used throughout this paper: 
 1 Regular alcohol use: at least 3 times per week over a period of 
at least 6 months during lifetime or in the last 12 months. 
 2 Harmful alcohol use: use of more than 40 g alcohol/day (fe-
males:  1 20 g/day) over any period of at least 6 months during 
lifetime or in the last 12 months. 
 3 Regular nicotine use: at least 4 weeks of daily use during life-
time. 
 4 Repeated use of illicit substances: use of illicit substances on 5 
or more occasions (includes prescription drugs in case of mis-
use) during lifetime or in the last 12 months. 
 5 Regular use of illicit substances: in the period of heaviest use at 
least monthly use of illicit substances (includes prescription 
drugs in case of misuse) during lifetime or in the last 12 
months. 
 We report lifetime prevalence at baseline, incidence rates cover-
ing the period between baseline and the second follow-up, cumula-
tive incidence rates covering the whole lifetime period until the 
second follow-up, and the 12-month prevalence rate covering the 
12 months before the second follow-up. For some analyses we also 
distinguish between pure and multiple (lifetime) use of substances. 
Multiple use is deﬁ ned as use of more than one substance not nec-
essarily during the same period. 
 Statistical Analysis 
 For those participants aged 14–17 years at baseline, the data in 
the present report are derived from the baseline, ﬁ rst follow-up, and 
second follow-up interviews. For those older than 17 years at base-
line, data from the baseline and (second) follow-up interview were 
used. Because only the younger cohort has been contacted at the 
ﬁ rst follow-up their data were cumulated between baseline and the 
second interview to cover the same period (see also overall design). 
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Data were weighted to consider different sampling probabilities as 
well as systematic non-response at baseline. The Stata Software 
package was used for robust inference of weighted data  [25] . Be-
cause 102 participants refused to openly answer questions on il-
licit substance use, analyses referring to illicit substances are based 
on 2,446 participants. Survival analyses were used to assess covari-
ates of the age-speciﬁ c cumulative incidence and the year of onset 
of substance use disorders. The curves were computed with the 
Kaplan Meier method and differences were assessed with hazard 
ratios (HRs) from Cox regression models. Constant factors were 
evaluated (e.g., age cohort; here the lifetime history was only con-
sidered through the maximum age of the younger cohort at the 
second follow-up = 21 years) as well as time-dependent factors
(e.g., prior nicotine dependence and its age at onset as covariates 
of  subsequent onset of alcohol use disorder). The assumption of the 
hazard ratio being independent of age was tested with Schoenfeld 
residuals  [26] . If this assumption was violated we added an interac-
tion term with age to the model. The model-based age-speciﬁ c haz-
ard ratio is given by HR (age) = HR main effect     HR interaction with age age . 
Whenever the age cohort and sex were not of explicit interest they 
were controlled for in stratiﬁ ed Cox regressions (i.e., different 
curves are calculated according to sex and age cohort before analyz-
ing differences due to covariates of interest)  [26] . 
 Results 
 Prevalence and Incidence of Substance Use Disorders 
 The top half of  table 1 shows the follow-up incidence 
and cumulative lifetime incidence rates for substance
use disorders by classes of substances. 43.8% of the sam-
ple met criteria for any abuse or dependence during life-
time by the time of the second follow-up. Nicotine depen-
dence was most common (24.8%); however, alcohol abuse 
was also relatively prevalent (19.3%) by the second fol-
low-up as a result of a high incidence since baseline. 15% 
fulﬁ lled criteria of dependence in the 12 months preced-
ing the follow-up interview. The majority of them en-
dorsed criteria for nicotine dependence (12.3%). Other 
12-month dependence diagnoses are much lower (e.g. il-
licit drug dependence, 0.9%). Most of those with abuse 
had used alcohol (8.9%). 
 Prevalence and Incidence of Regular Substance Use 
 The bottom half of  table 1 shows the follow-up inci-
dence and cumulative lifetime incidence rate for several 
categories of regular substance use. Nearly 60% of the 
sample had been regular users of any substance at some 
point in their lives. 12-month rates of any regular use were 
also high with 47.8% in the year before the second follow-
up assessment. Regular use of nicotine was most common 
(39.2%). About one third of the sample had been regular 
users of any substance in the past 12 months but had 
never met the criteria for dependence. Interestingly, reg-
ular illicit drug use was nearly as frequent as alcohol use 
in this group. 12-month rates of regular illicit drug use 
without abuse and dependence were higher than the re-
spective rates for regular alcohol use (7.8 vs. 6.7%). This 
might indicate a tendency of a different use pattern with 
more binge drinking on the one hand and more continu-
ous use of illicit substances on the other hand. 
 Age-Speciﬁ c Incidence Rates of Abuse and 
Dependence 
 Effects of Different Age Cohorts 
 One hypothesis of our examination was that age at on-
set and age-speciﬁ c incidence rates of abuse and depen-
dence would differ by age cohorts. Younger cohorts 
should have higher age-speciﬁ c and cumulative incidence 
rates and an earlier age at onset. To examine these effects 
of age we compared the age-speciﬁ c incidence rates of 
those 14–17 years old at baseline to those 18–24 years old 
at baseline. The younger cohort was 18–21 years old in 
1999 and the older cohort 22–28 years old.  Figure 1 shows 
the curves for these two cohorts by age at onset of alcohol, 
nicotine, and illicit drug use disorders until the age of 21 
years, the highest age in the younger cohort. The highest 
cumulative rates were found for alcohol abuse and depen-
dence in both cohorts. Yet the age-speciﬁ c incidence dif-
fers signiﬁ cantly by age cohort across all substance class-
es (alcohol: HR = 0.7, 95% CI 0.6–0.8; nicotine: HR = 
0.7, 95% CI 0.6–0.8; illicit substances: HR = 0.5, 95% CI 
0.4–0.7). The most pronounced cohort difference was ob-
served among those with illicit substance use disorders, 
in that cumulative incidence rates were doubled in the 
younger cohort. Furthermore, the median age at onset 
was between 1 and 3 years earlier in members of the 
younger cohort, which was a signiﬁ cant trend across all 
substance classes. This ﬁ nding was slightly more pro-
nounced for nicotine dependence (alcohol: HR = 1.4, 95% 
CI 1.2–1.5; nicotine: HR = 1.6, 95% CI 1.3–1.8; illicit 
substances: HR = 1.2, 95% CI 1.0–1.5). 
 Sequelae of Onsets of Substance Use Disorders 
 We also tested the hypothesis that an earlier age at on-
set of nicotine dependence would be associated with a 
higher risk of onset of another substance use disorder. 
This hypothesis was not supported with respect to alcohol 
abuse or dependence. However, individuals with prior 
nicotine dependence had an elevated overall risk for sub-
sequent illicit substance use disorder (HR = 2.6, 95% CI 
1.7–4.0). Subsequent onset of illicit substance use disor-
ders did not depend on age (  2  (1) = 0.57, p = 0.45) or age 
at onset of nicotine dependence (HR = 0.9 per year, 95% 
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CI 0.6–1.9). However, an age  ! age at onset interaction 
term was signiﬁ cant in predicting the subsequent onset of 
illicit drug use disorder (  2  (1) = 4.80, p = 0.03). Later 
onset of nicotine dependence co-occurred with an in-
creased risk of illicit substance use disorders up to 21 
years. After that age, hazard ratios decreased with the 
later onset of nicotine dependence (HR main effect  = 
33.67    HR interaction with age  = 0.85age, 95% CI 0.78–0.92). 
 Regular Use of Different Substance Classes by Age 
Cohorts 
 We further analyzed patterns and frequencies of pure 
(only one substance) and multiple (more than one sub-
stance) substance use.  Figure 2 shows the cumulative life-
time incidences of the different subgroups of regular sub-
stance users by combinations of substances for the two 
different age cohorts. Pure lifetime nicotine users were 
the most frequent in the younger (14.9%) and older cohort 
Table 1. Cumulated lifetime incidence and 12-month prevalence rates of substance use and substance use disorders in the EDSP sample 
at second follow-up
Diagnostic and substance
user groups
Lifetime prevalence
at baseline1
Incidence between base-
line and second follow-up1, 2
Cumulative lifetime inci-
dence at second follow-up1
12-month prevalence
at second follow-up1
n % 95% CI n % 95% CI n % 95% CI n % 95% CI
Any abuse or dependence 596 28.6 26.6–30.7 451 21.3 19.3–23.3 1,047 43.8 41.6–46.0 607 24.4 22.5–26.3
Any abuse or dependence w/o nicotine
dependence 371 18.0 16.3–19.9 390 16.4 14.8–18.2 761 31.5 29.5–33.6 399 15.5 14.0–17.2
Any dependence 434 21.1 19.3–23.1 268 10.8 9.5–12.3 702 29.7 27.7–31.8 368 15.0 13.4–16.6
Any dependence w/o nicotine
dependence 143 7.5 6.1–8.6 106 4.1 3.3–5.1 249 11.0 9.7–12.6 100 3.9 3.2–4.9
Any abuse 256 12.2 10.7–13.7 332 13.2 11.8–14.8 574 23.1 21.3–25.0 289 10.8 9.5–12.2
Any alcohol abuse or dependence 332 15.9 14.3–17.7 382 15.0 13.5–16.7 714 28.5 26.6–30.6 362 13.6 12.2–15.2
Alcohol dependence 119 6.0 5.0–7.2 96 3.5 2.8–4.3 215 9.2 8.0–10.6 86 3.3 2.6–4.1
Alcohol abuse 213 9.9 8.6–11.4 302 11.1 9.9–12.6 499 19.3 17.6–21.1 245 8.9 7.7–10.2
Nicotine dependence 380 17.7 16.0–19.5 235 8.7 7.5–10.0 615 24.8 23.0–26.8 318 12.3 11.0–13.9
Illicit drug abuse or dependence 97 4.3 3.5–5.3 123 4.4 3.7–5.4 220 8.6 7.4–9.9 112 3.9 3.2–4.8
Illicit drug dependence 38 1.8 1.3–2.6 33 1.3 0.9–1.9 71 3.1 2.4–4.0 22 0.9 0.5–1.4
Illicit drug abuse 65 2.8 2.2–3.7 104 3.7 3.0–4.6 166 6.3 5.3–7.4 83 2.8 2.2–3.5
Any regular use 903 42.9 40.6–45.1 517 28.5 26.1–31.0 1,420 59.1 56.9–61.3 1,183 47.8 45.6–50.0
Any regular use w/o dependence 480 22.2 20.4–24.2 367 15.7 14.1–17.5 728 29.8 27.8–31.9 828 33.4 31.4–35.5
Any regular use w/o abuse and
dependence 390 18.0 16.3–19.8 268 11.1 9.7–12.6 509 21.1 19.4–23.0 683 2.0 14.0–17.2
Regular alcohol use3 340 18.0 16.2–19.9 271 12.3 10.8–13.9 611 28.1 26.1–30.1 318 14.5 13.0–16.2
Regular alcohol use3 w/o dependence 257 13.6 12.0–15.3 216 9.8 8.5–11.3 456 20.9 19.1–22.8 238 10.7 9.4–12.2
Regular alcohol use3 w/o abuse and 
dependence 178 9.2 7.9–10.7 126 5.1 4.2–6.1 272 12.8 11.3–14.4 141 6.7 5.6–7.9
Regular w/o harmful use, dependence 165 8.6 7.4–10.0 127 6.1 5.0–7.3 261 12.2 10.7–13.8 194 9.0 7.8–10.4
Harmful alcohol use4 151 8.2 7.0–9.6 165 6.8 5.8–8.0 316 14.4 12.9–16.1 109 4.8 3.9–5.8
Regular nicotine use5 760 34.2 32.1–36.3 447 19.7 17.8–21.6 1,207 47.1 44.9–49.3 1,035 39.2 37.1–41.4
Regular nicotine use w/o dependence 380 16.5 14.9–18.2 311 9.4 8.3–10.6 592 22.3 20.5–24.1 721 27.1 25.2–29.0
Repeated illicit drug use6 358 17.9 16.2–19.8 424 17.6 15.9–19.3 782 32.3 30.3–34.5 396 14.7 13.2–16.2
Regular illicit drug use7 262 12.6 11.2–14.3 226 8.3 7.2–9.5 488 19.9 18.2–21.7 305 11.0 9.8–12.4
Regular illicit drug use w/o dependence 225 10.9 9.5–12.4 206 7.4 6.4–8.5 419 16.9 15.3–18.6 283 10.2 9.0–11.5
Regular illicit drug use w/o abuse and
dependence 171 8.6 7.4–10.0 149 4.7 3.9–5.5 294 12.3 10.9–13.8 211 7.8 6.7–9.0
1 Unweighted number, weighted percent, 95% conﬁ dence interval.
2 Substance use categories excluding diagnostic subgroups (e.g. any regular use without dependence) are deﬁ ned as incidence of use in this category never fulﬁ ll-
ing criteria for the diagnosis under consideration until baseline or second follow-up. The cumulated rates in these categories are lower than the summarized numbers 
of baseline and incident cases because a person with substance use until baseline can be counted in these categories despite abuse or dependence in the follow-up 
period.
3 Regular alcohol use: at least three times per week over a period of at least 6 months (lifetime until the second follow-up).
4 Harmful alcohol use (males: use of >40 g alcohol/day; females: >20 g/day) over a period of at least about 6 months.
5 Regular nicotine use: daily use of nicotine for at least 4 weeks.
6 Repeated illicit drug use: the use at least 5 times of any illicit drug. 
7 Regular illicit drug use: 5 times or more and at least once a month during the period of heaviest use.
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age of 21 years. 
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(16.4%) at baseline. At follow-up the cumulative inci-
dence of pure regular nicotine use had nearly duplicated 
in the younger cohort (24.7%) in contrast to the older co-
hort (19.5%). Furthermore nicotine and illicit drug use 
was nearly three times higher in the younger cohort at the 
second follow-up (11.8%). In the older cohort more par-
ticipants used alcohol regularly, particularly among those 
who had also used other substances. Interestingly, despite 
the signiﬁ cantly higher rates of alcohol abuse and depen-
dence in the younger cohort until the age of 21 years ( ﬁ g. 
1 ), there were more regular pure users of alcohol and reg-
ular multiple users of alcohol and other substances in the 
older cohort. 
 Regular Use of Different Substance Classes by Gender 
 The analysis on pure and multiple regular lifetime use 
was also conducted separately for males and females as 
shown in  ﬁ gure 3 . Pure nicotine use had the highest cu-
mulative lifetime incidence at both assessment times 
among females (19.7 and 26.8%) and males (12.3 and 
15.3%). However, rates of pure illicit drug use were low 
among both. As opposed to females (4.4%), multiple use 
of all three classes of substances was a more frequent use 
pattern at follow-up among males (13.0%). Alcohol, which 
also contributes to this group, seems to account for most 
of the gender differences. 
 Discussion 
 Prevalence and Incidence of Abuse and Dependence 
 The current investigation represents the only longitu-
dinal epidemiological study of a representative popula-
tion sample of European adolescents using standardized 
clinical interviews to assess DSM-IV substance abuse and 
dependence of all substance classes. The importance of 
utilizing standard diagnostic criteria for substance abuse 
and dependence has often been discussed  [27, 28] , but 
prior to the current study has not been accomplished in 
the European monitoring system of substance use or in 
studies of adolescents. The key ﬁ nding of the present 
study is the high incidence of substance abuse and depen-
dence since the baseline investigation and the resulting 
high cumulative lifetime incidence rates at the second 
follow-up assessment. This ﬁ nding is important because 
substance use care is limited  [29] . 
 The extent of abuse and dependence in our sample, as 
well as the frequency of repeated and regular use, is con-
cerning. Nearly 1 in 4 met criteria for a diagnosis of a 
substance use disorder in the past 12 months, and 15% 
met criteria for substance dependence. Almost half of all 
adolescents and young adults used substances regularly 
in the past 12 months. Repeated use of illicit substances 
( 1 5 times) is as frequent as regular alcohol use and the 
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 Fig. 3. Cumulative incidence rates of speciﬁ c patterns of pure and multiple regular lifetime substance use at base-
line and follow-up by gender. 
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use of illicit substances in regular intervals is twice as high 
as harmful alcohol use. Comparisons of these ﬁ ndings 
with those of other studies are difﬁ cult due to variable 
sample characteristics; however, it is worthwhile to note 
some discrepancies. For example, Warner et al.  [8] re-
ported lower rates of substance abuse and dependence in 
a younger US cohort. When our ﬁ ndings regarding 18-
year-olds are compared to those of the same age group 
reported by Young et al.  [9] , dependence estimates in our 
German sample are higher for nicotine dependence and 
alcohol dependence. While results on nicotine depen-
dence should be interpreted somewhat cautiously, as de-
creased rates of teen smoking have been reported in re-
cent surveys  [30] , there remains a higher rate of alcohol 
dependence in our sample which might be due to the 
higher rates of alcohol use in Germany compared to oth-
er countries  [5] . Only illicit drug abuse and dependence 
appear more frequently in the US samples, although lev-
els of repeated illicit drug use are comparable. On the 
other hand, compared to other European surveys (e.g., 
questionnaire surveys), our estimates of regular substance 
use are higher  [12] . There could be methodological rea-
sons for these differences; for instance, questionnaire-
based studies may underestimate substance use com-
pared to studies that employ face-to-face interviews. The 
presence of true regional differences in substance use 
might also explain the discrepancies among ﬁ ndings of 
various studies. Cultural inﬂ uences could be responsible 
for different substance use patterns (e.g. the amount and 
speciﬁ c type of substance) as well as for speciﬁ c response 
patterns  [5] in questionnaires and interviews on sub-
stance use problems. For example, the higher rates of drug 
abuse and dependence might be associated with different 
use patterns or different amounts of the active agent on 
the one hand in the US and underreporting of symptoms 
in European countries on the other hand. Nevertheless 
these questions should also be addressed in further stud-
ies directly comparing data with identical instruments. 
 Cohort Trends and Patterns of Use 
 We also reported signiﬁ cantly higher rates of abuse 
and dependence in younger age cohorts born after 1978. 
Such signiﬁ cant age cohort effects on the use of alcohol, 
illicit drugs, and nicotine, as well as a trend toward ear-
lier ages at onset of use, have also been observed in sev-
eral other studies  [31] . However, there were few prior 
reports of cohort effects on age at onset and age-speciﬁ c 
incidence of abuse and dependence. One exception was 
the ﬁ nding of Grant et al.  [32] that an earlier age at onset 
of drug use predicts drug abuse and the development of 
alcohol dependence. We explored this kind of association 
with nicotine dependence as a predictor for the onset of 
other substance use disorders. 
 We found no signiﬁ cant associations of nicotine de-
pendence with later alcohol abuse or dependence; how-
ever, nicotine dependence was associated with a higher 
risk of illicit drug abuse and dependence. But this asso-
ciation was qualiﬁ ed by consideration of age at onset of 
nicotine dependence. Among those with nicotine depen-
dence a later age at onset co-occurred with an increased 
risk for illicit substance use disorders in younger age 
groups up to 21 years. This could be associated with ear-
lier ages at onset of drug use disorders among younger age 
cohorts and a modiﬁ ed pattern of nicotine use. More de-
tailed analyses of these data revealed that younger age 
groups with illicit drug use disorders also had a signiﬁ cant 
risk for secondary nicotine dependence. Furthermore, 
our analysis of pure and multiple regular lifetime use of 
psychotropic substances showed that lifetime regular nic-
otine-illicit drug users are the most frequent group in the 
younger cohort and the second most frequent group 
among females. Because the use of cannabis is not inde-
pendent of nicotine use this could also be a pathway to 
nicotine dependence in younger cohorts. Therefore, pri-
mary and secondary prevention of illicit drug use should 
include nicotine dependence among risk groups. On the 
other hand, as incidence rates of primary nicotine use 
increase after the age of 13 years, very early preventive 
strategies are needed. Findings from other countries on 
decreased prevalence rates of nicotine use and depen-
dence indicate that such preventive strategies might be 
effective. 
 Limitations 
 This study has a number of strengths, including the 
standardized assessment of DSM-IV abuse and depen-
dence with a structured interview, the longitudinal de-
sign, and the representative community sample; howev-
er, some limitations should be noted. First, the ﬁ ndings 
are based on self-reported use and symptoms, which re-
quires accurate recall of onset, amount, and symptoms 
associated with substance use. Recall bias may be present, 
although it might be less severe given the use of a young 
sample and close follow-up periods. Second, results re-
garding cohort trends of abuse and dependence might be 
a byproduct of response bias associated with age- and 
substance-speciﬁ c trends in reporting symptoms of abuse 
or dependence  [33] . Third, longitudinal studies are asso-
ciated with attrition during follow-up periods that also 
can be a source of bias. In our study we found no selective 
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attrition among those with alcohol or illicit drug use dis-
orders, but a slightly higher rate of nicotine dependence 
among non-responders was observed. Estimates for nico-
tine dependence might therefore reﬂ ect lower bound es-
timates. Despite the possibility of attrition-related bias, 
it is important to note that the overall response rate of 
this follow-up is relatively high with 84% of the baseline 
sample carried through the 42-month follow-up period. 
Fourth, there is still an ongoing discussion about diagnos-
tic criteria of dependence for speciﬁ c substances, espe-
cially cannabis. This investigation could not address this 
question; however, in another paper we were able to show 
that regular cannabis use was associated with the devel-
opment of a dependence syndrome  [34] . Therefore we 
think that the use of diagnostic criteria in this study is jus-
tiﬁ ed although further studies are needed. Finally, it should 
be noted that this community sample is comprised of a 
relatively well-educated and economically endowed urban 
population. Estimates might not be representative of Ger-
many as a whole or of other European regions. For com-
parisons across regions and countries more studies with 
the methodology of personal interviews and standardized 
criteria are necessary especially among adolescents. They 
can complement those large-scale surveys with question-
naires adding ﬁ ndings based on standardized clinically rel-
evant criteria from personalized interviews. 
 In conclusion, results from the present study indicate 
high rates of substance use disorders in adolescents and 
young adults of this German region that are comparable 
to estimates from US studies, though rates pertaining to 
speciﬁ c substances differ across the two countries. We 
found a signiﬁ cant trend toward earlier ages at onset of 
substance use disorders in younger cohorts, which may 
be partly responsible for the high rates of illicit drug abuse 
and dependence we encountered. Early primary preven-
tion of nicotine use and secondary prevention of nicotine 
dependence should be one major focus to reduce the risk 
for development of other substance use disorders in ado-
lescents. 
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